Literature DB >> 17888664

Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase.

Victor B Luzhkov1, Barbara Selisko, Anneli Nordqvist, Frédéric Peyrane, Etienne Decroly, Karine Alvarez, Anders Karlen, Bruno Canard, Johan Qvist.   

Abstract

We report high-throughput structure-based virtual screening of putative Flavivirus 2'-O-methyltransferase inhibitors together with results from subsequent bioassay tests of selected compounds. Potential inhibitors for the S-adenosylmethionine binding site were explored using 2D similarity searching, pharmacophore filtering and docking. The inhibitory activities of 15 top-ranking compounds from the docking calculations were tested on a recombinant methyltransferase with the RNA substrate (7Me)GpppAC(5). Local and global docking simulations were combined to estimate the ligand selectivity for the target site. The results of the combined computational and experimental screening identified a novel inhibitor, with a previously unknown scaffold, that has an IC(50) value of 60 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888664     DOI: 10.1016/j.bmc.2007.08.049

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

1.  Identification and Characterization of Novel Broad-Spectrum Inhibitors of the Flavivirus Methyltransferase.

Authors:  Matthew Brecher; Hui Chen; Zhong Li; Nilesh K Banavali; Susan A Jones; Jing Zhang; Laura D Kramer; Hongmin Li
Journal:  ACS Infect Dis       Date:  2015-07-31       Impact factor: 5.084

Review 2.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

3.  Flavivirus RNA cap methyltransferase: structure, function, and inhibition.

Authors:  Lihui Liu; Hongping Dong; Hui Chen; Jing Zhang; Hua Ling; Zhong Li; Pei-Yong Shi; Hongmin Li
Journal:  Front Biol (Beijing)       Date:  2010-08-01

4.  Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies.

Authors:  Prasenjit Mukherjee; Falgun Shah; Prashant Desai; Mitchell Avery
Journal:  J Chem Inf Model       Date:  2011-05-23       Impact factor: 4.956

5.  An investigation of phenylthiazole antiflaviviral agents.

Authors:  Abdelrahman S Mayhoub; Mansoora Khaliq; Carolyn Botting; Ze Li; Richard J Kuhn; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2011-05-03       Impact factor: 3.641

6.  Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.

Authors:  Kim Long Yeo; Yen-Liang Chen; Hao Ying Xu; Hongping Dong; Qing-Yin Wang; Fumiaki Yokokawa; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

7.  Identification and Characterization of a Ribose 2'-O-Methyltransferase Encoded by the Ronivirus Branch of Nidovirales.

Authors:  Cong Zeng; Andong Wu; Yi Wang; Shan Xu; Yingke Tang; Xu Jin; Shilei Wang; Lei Qin; Ying Sun; Chengpeng Fan; Eric J Snijder; Benjamin W Neuman; Yu Chen; Tero Ahola; Deyin Guo
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

8.  In vitro reconstitution of SARS-coronavirus mRNA cap methylation.

Authors:  Mickaël Bouvet; Claire Debarnot; Isabelle Imbert; Barbara Selisko; Eric J Snijder; Bruno Canard; Etienne Decroly
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

Review 9.  Flavivirus methyltransferase: a novel antiviral target.

Authors:  Hongping Dong; Bo Zhang; Pei-Yong Shi
Journal:  Antiviral Res       Date:  2008-06-05       Impact factor: 5.970

10.  Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity.

Authors:  Etienne Decroly; Isabelle Imbert; Bruno Coutard; Mickaël Bouvet; Barbara Selisko; Karine Alvarez; Alexander E Gorbalenya; Eric J Snijder; Bruno Canard
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.